Global Cisplatin Market Growth (Status and Outlook) 2025-2031
According to this study, the global Cisplatin market size will reach US$ million by 2031.
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
United States market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cisplatin players cover Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Cisplatin Industry Forecast” looks at past sales and reviews total world Cisplatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Cisplatin sales for 2025 through 2031. With Cisplatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cisplatin industry.
This Insight Report provides a comprehensive analysis of the global Cisplatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cisplatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cisplatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cisplatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cisplatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Cisplatin market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
United States market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cisplatin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cisplatin players cover Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Cisplatin Industry Forecast” looks at past sales and reviews total world Cisplatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Cisplatin sales for 2025 through 2031. With Cisplatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cisplatin industry.
This Insight Report provides a comprehensive analysis of the global Cisplatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cisplatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cisplatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cisplatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cisplatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Cisplatin market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Tablets
- Injection
- Testicular Cancer
- Osteosarcoma
- Breast Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly and Company
- Hospira
- Pfizer
- Bedford Pharmaceuticals
- Alvogen
- Athenex Pharmaceutical
- Gland Pharma (Fosun Pharma)
- West-Ward Pharmaceuticals
- WG Critical Care
- David Bull Laboratories
- Omega Laboratories
- Fresenius Kabi
- TEVA
- Mylan Pharmaceuticals
- Yunnan Plant Pharmaceutical
- Yunnan Biological Valley Pharmaceutical
- Dezhou de Pharmaceutical
- Jiangsu Haosen Pharmaceutical Group
- Qilu Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cisplatin Market Size (2020-2031)
2.1.2 Cisplatin Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cisplatin by Country/Region (2020, 2024 & 2031)
2.2 Cisplatin Segment by Type
2.2.1 Tablets
2.2.2 Injection
2.3 Cisplatin Market Size by Type
2.3.1 Cisplatin Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cisplatin Market Size Market Share by Type (2020-2025)
2.4 Cisplatin Segment by Application
2.4.1 Testicular Cancer
2.4.2 Osteosarcoma
2.4.3 Breast Cancer
2.5 Cisplatin Market Size by Application
2.5.1 Cisplatin Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cisplatin Market Size Market Share by Application (2020-2025)
3 CISPLATIN MARKET SIZE BY PLAYER
3.1 Cisplatin Market Size Market Share by Player
3.1.1 Global Cisplatin Revenue by Player (2020-2025)
3.1.2 Global Cisplatin Revenue Market Share by Player (2020-2025)
3.2 Global Cisplatin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CISPLATIN BY REGION
4.1 Cisplatin Market Size by Region (2020-2025)
4.2 Global Cisplatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cisplatin Market Size Growth (2020-2025)
4.4 APAC Cisplatin Market Size Growth (2020-2025)
4.5 Europe Cisplatin Market Size Growth (2020-2025)
4.6 Middle East & Africa Cisplatin Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Cisplatin Market Size by Country (2020-2025)
5.2 Americas Cisplatin Market Size by Type (2020-2025)
5.3 Americas Cisplatin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cisplatin Market Size by Region (2020-2025)
6.2 APAC Cisplatin Market Size by Type (2020-2025)
6.3 APAC Cisplatin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cisplatin Market Size by Country (2020-2025)
7.2 Europe Cisplatin Market Size by Type (2020-2025)
7.3 Europe Cisplatin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cisplatin by Region (2020-2025)
8.2 Middle East & Africa Cisplatin Market Size by Type (2020-2025)
8.3 Middle East & Africa Cisplatin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CISPLATIN MARKET FORECAST
10.1 Global Cisplatin Forecast by Region (2026-2031)
10.1.1 Global Cisplatin Forecast by Region (2026-2031)
10.1.2 Americas Cisplatin Forecast
10.1.3 APAC Cisplatin Forecast
10.1.4 Europe Cisplatin Forecast
10.1.5 Middle East & Africa Cisplatin Forecast
10.2 Americas Cisplatin Forecast by Country (2026-2031)
10.2.1 United States Market Cisplatin Forecast
10.2.2 Canada Market Cisplatin Forecast
10.2.3 Mexico Market Cisplatin Forecast
10.2.4 Brazil Market Cisplatin Forecast
10.3 APAC Cisplatin Forecast by Region (2026-2031)
10.3.1 China Cisplatin Market Forecast
10.3.2 Japan Market Cisplatin Forecast
10.3.3 Korea Market Cisplatin Forecast
10.3.4 Southeast Asia Market Cisplatin Forecast
10.3.5 India Market Cisplatin Forecast
10.3.6 Australia Market Cisplatin Forecast
10.4 Europe Cisplatin Forecast by Country (2026-2031)
10.4.1 Germany Market Cisplatin Forecast
10.4.2 France Market Cisplatin Forecast
10.4.3 UK Market Cisplatin Forecast
10.4.4 Italy Market Cisplatin Forecast
10.4.5 Russia Market Cisplatin Forecast
10.5 Middle East & Africa Cisplatin Forecast by Region (2026-2031)
10.5.1 Egypt Market Cisplatin Forecast
10.5.2 South Africa Market Cisplatin Forecast
10.5.3 Israel Market Cisplatin Forecast
10.5.4 Turkey Market Cisplatin Forecast
10.6 Global Cisplatin Forecast by Type (2026-2031)
10.7 Global Cisplatin Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cisplatin Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Cisplatin Product Offered
11.1.3 Eli Lilly and Company Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Eli Lilly and Company Main Business Overview
11.1.5 Eli Lilly and Company Latest Developments
11.2 Hospira
11.2.1 Hospira Company Information
11.2.2 Hospira Cisplatin Product Offered
11.2.3 Hospira Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hospira Main Business Overview
11.2.5 Hospira Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Cisplatin Product Offered
11.3.3 Pfizer Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bedford Pharmaceuticals
11.4.1 Bedford Pharmaceuticals Company Information
11.4.2 Bedford Pharmaceuticals Cisplatin Product Offered
11.4.3 Bedford Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bedford Pharmaceuticals Main Business Overview
11.4.5 Bedford Pharmaceuticals Latest Developments
11.5 Alvogen
11.5.1 Alvogen Company Information
11.5.2 Alvogen Cisplatin Product Offered
11.5.3 Alvogen Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Alvogen Main Business Overview
11.5.5 Alvogen Latest Developments
11.6 Athenex Pharmaceutical
11.6.1 Athenex Pharmaceutical Company Information
11.6.2 Athenex Pharmaceutical Cisplatin Product Offered
11.6.3 Athenex Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Athenex Pharmaceutical Main Business Overview
11.6.5 Athenex Pharmaceutical Latest Developments
11.7 Gland Pharma (Fosun Pharma)
11.7.1 Gland Pharma (Fosun Pharma) Company Information
11.7.2 Gland Pharma (Fosun Pharma) Cisplatin Product Offered
11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gland Pharma (Fosun Pharma) Main Business Overview
11.7.5 Gland Pharma (Fosun Pharma) Latest Developments
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Information
11.8.2 West-Ward Pharmaceuticals Cisplatin Product Offered
11.8.3 West-Ward Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 West-Ward Pharmaceuticals Main Business Overview
11.8.5 West-Ward Pharmaceuticals Latest Developments
11.9 WG Critical Care
11.9.1 WG Critical Care Company Information
11.9.2 WG Critical Care Cisplatin Product Offered
11.9.3 WG Critical Care Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 WG Critical Care Main Business Overview
11.9.5 WG Critical Care Latest Developments
11.10 David Bull Laboratories
11.10.1 David Bull Laboratories Company Information
11.10.2 David Bull Laboratories Cisplatin Product Offered
11.10.3 David Bull Laboratories Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 David Bull Laboratories Main Business Overview
11.10.5 David Bull Laboratories Latest Developments
11.11 Omega Laboratories
11.11.1 Omega Laboratories Company Information
11.11.2 Omega Laboratories Cisplatin Product Offered
11.11.3 Omega Laboratories Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Omega Laboratories Main Business Overview
11.11.5 Omega Laboratories Latest Developments
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Information
11.12.2 Fresenius Kabi Cisplatin Product Offered
11.12.3 Fresenius Kabi Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Fresenius Kabi Main Business Overview
11.12.5 Fresenius Kabi Latest Developments
11.13 TEVA
11.13.1 TEVA Company Information
11.13.2 TEVA Cisplatin Product Offered
11.13.3 TEVA Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TEVA Main Business Overview
11.13.5 TEVA Latest Developments
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Information
11.14.2 Mylan Pharmaceuticals Cisplatin Product Offered
11.14.3 Mylan Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Mylan Pharmaceuticals Main Business Overview
11.14.5 Mylan Pharmaceuticals Latest Developments
11.15 Yunnan Plant Pharmaceutical
11.15.1 Yunnan Plant Pharmaceutical Company Information
11.15.2 Yunnan Plant Pharmaceutical Cisplatin Product Offered
11.15.3 Yunnan Plant Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Yunnan Plant Pharmaceutical Main Business Overview
11.15.5 Yunnan Plant Pharmaceutical Latest Developments
11.16 Yunnan Biological Valley Pharmaceutical
11.16.1 Yunnan Biological Valley Pharmaceutical Company Information
11.16.2 Yunnan Biological Valley Pharmaceutical Cisplatin Product Offered
11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Yunnan Biological Valley Pharmaceutical Main Business Overview
11.16.5 Yunnan Biological Valley Pharmaceutical Latest Developments
11.17 Dezhou de Pharmaceutical
11.17.1 Dezhou de Pharmaceutical Company Information
11.17.2 Dezhou de Pharmaceutical Cisplatin Product Offered
11.17.3 Dezhou de Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Dezhou de Pharmaceutical Main Business Overview
11.17.5 Dezhou de Pharmaceutical Latest Developments
11.18 Jiangsu Haosen Pharmaceutical Group
11.18.1 Jiangsu Haosen Pharmaceutical Group Company Information
11.18.2 Jiangsu Haosen Pharmaceutical Group Cisplatin Product Offered
11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
11.18.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Company Information
11.19.2 Qilu Pharmaceutical Cisplatin Product Offered
11.19.3 Qilu Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Qilu Pharmaceutical Main Business Overview
11.19.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cisplatin Market Size (2020-2031)
2.1.2 Cisplatin Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cisplatin by Country/Region (2020, 2024 & 2031)
2.2 Cisplatin Segment by Type
2.2.1 Tablets
2.2.2 Injection
2.3 Cisplatin Market Size by Type
2.3.1 Cisplatin Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cisplatin Market Size Market Share by Type (2020-2025)
2.4 Cisplatin Segment by Application
2.4.1 Testicular Cancer
2.4.2 Osteosarcoma
2.4.3 Breast Cancer
2.5 Cisplatin Market Size by Application
2.5.1 Cisplatin Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cisplatin Market Size Market Share by Application (2020-2025)
3 CISPLATIN MARKET SIZE BY PLAYER
3.1 Cisplatin Market Size Market Share by Player
3.1.1 Global Cisplatin Revenue by Player (2020-2025)
3.1.2 Global Cisplatin Revenue Market Share by Player (2020-2025)
3.2 Global Cisplatin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CISPLATIN BY REGION
4.1 Cisplatin Market Size by Region (2020-2025)
4.2 Global Cisplatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cisplatin Market Size Growth (2020-2025)
4.4 APAC Cisplatin Market Size Growth (2020-2025)
4.5 Europe Cisplatin Market Size Growth (2020-2025)
4.6 Middle East & Africa Cisplatin Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Cisplatin Market Size by Country (2020-2025)
5.2 Americas Cisplatin Market Size by Type (2020-2025)
5.3 Americas Cisplatin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cisplatin Market Size by Region (2020-2025)
6.2 APAC Cisplatin Market Size by Type (2020-2025)
6.3 APAC Cisplatin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cisplatin Market Size by Country (2020-2025)
7.2 Europe Cisplatin Market Size by Type (2020-2025)
7.3 Europe Cisplatin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cisplatin by Region (2020-2025)
8.2 Middle East & Africa Cisplatin Market Size by Type (2020-2025)
8.3 Middle East & Africa Cisplatin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CISPLATIN MARKET FORECAST
10.1 Global Cisplatin Forecast by Region (2026-2031)
10.1.1 Global Cisplatin Forecast by Region (2026-2031)
10.1.2 Americas Cisplatin Forecast
10.1.3 APAC Cisplatin Forecast
10.1.4 Europe Cisplatin Forecast
10.1.5 Middle East & Africa Cisplatin Forecast
10.2 Americas Cisplatin Forecast by Country (2026-2031)
10.2.1 United States Market Cisplatin Forecast
10.2.2 Canada Market Cisplatin Forecast
10.2.3 Mexico Market Cisplatin Forecast
10.2.4 Brazil Market Cisplatin Forecast
10.3 APAC Cisplatin Forecast by Region (2026-2031)
10.3.1 China Cisplatin Market Forecast
10.3.2 Japan Market Cisplatin Forecast
10.3.3 Korea Market Cisplatin Forecast
10.3.4 Southeast Asia Market Cisplatin Forecast
10.3.5 India Market Cisplatin Forecast
10.3.6 Australia Market Cisplatin Forecast
10.4 Europe Cisplatin Forecast by Country (2026-2031)
10.4.1 Germany Market Cisplatin Forecast
10.4.2 France Market Cisplatin Forecast
10.4.3 UK Market Cisplatin Forecast
10.4.4 Italy Market Cisplatin Forecast
10.4.5 Russia Market Cisplatin Forecast
10.5 Middle East & Africa Cisplatin Forecast by Region (2026-2031)
10.5.1 Egypt Market Cisplatin Forecast
10.5.2 South Africa Market Cisplatin Forecast
10.5.3 Israel Market Cisplatin Forecast
10.5.4 Turkey Market Cisplatin Forecast
10.6 Global Cisplatin Forecast by Type (2026-2031)
10.7 Global Cisplatin Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cisplatin Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Cisplatin Product Offered
11.1.3 Eli Lilly and Company Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Eli Lilly and Company Main Business Overview
11.1.5 Eli Lilly and Company Latest Developments
11.2 Hospira
11.2.1 Hospira Company Information
11.2.2 Hospira Cisplatin Product Offered
11.2.3 Hospira Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hospira Main Business Overview
11.2.5 Hospira Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Cisplatin Product Offered
11.3.3 Pfizer Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bedford Pharmaceuticals
11.4.1 Bedford Pharmaceuticals Company Information
11.4.2 Bedford Pharmaceuticals Cisplatin Product Offered
11.4.3 Bedford Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bedford Pharmaceuticals Main Business Overview
11.4.5 Bedford Pharmaceuticals Latest Developments
11.5 Alvogen
11.5.1 Alvogen Company Information
11.5.2 Alvogen Cisplatin Product Offered
11.5.3 Alvogen Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Alvogen Main Business Overview
11.5.5 Alvogen Latest Developments
11.6 Athenex Pharmaceutical
11.6.1 Athenex Pharmaceutical Company Information
11.6.2 Athenex Pharmaceutical Cisplatin Product Offered
11.6.3 Athenex Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Athenex Pharmaceutical Main Business Overview
11.6.5 Athenex Pharmaceutical Latest Developments
11.7 Gland Pharma (Fosun Pharma)
11.7.1 Gland Pharma (Fosun Pharma) Company Information
11.7.2 Gland Pharma (Fosun Pharma) Cisplatin Product Offered
11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gland Pharma (Fosun Pharma) Main Business Overview
11.7.5 Gland Pharma (Fosun Pharma) Latest Developments
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Information
11.8.2 West-Ward Pharmaceuticals Cisplatin Product Offered
11.8.3 West-Ward Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 West-Ward Pharmaceuticals Main Business Overview
11.8.5 West-Ward Pharmaceuticals Latest Developments
11.9 WG Critical Care
11.9.1 WG Critical Care Company Information
11.9.2 WG Critical Care Cisplatin Product Offered
11.9.3 WG Critical Care Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 WG Critical Care Main Business Overview
11.9.5 WG Critical Care Latest Developments
11.10 David Bull Laboratories
11.10.1 David Bull Laboratories Company Information
11.10.2 David Bull Laboratories Cisplatin Product Offered
11.10.3 David Bull Laboratories Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 David Bull Laboratories Main Business Overview
11.10.5 David Bull Laboratories Latest Developments
11.11 Omega Laboratories
11.11.1 Omega Laboratories Company Information
11.11.2 Omega Laboratories Cisplatin Product Offered
11.11.3 Omega Laboratories Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Omega Laboratories Main Business Overview
11.11.5 Omega Laboratories Latest Developments
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Information
11.12.2 Fresenius Kabi Cisplatin Product Offered
11.12.3 Fresenius Kabi Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Fresenius Kabi Main Business Overview
11.12.5 Fresenius Kabi Latest Developments
11.13 TEVA
11.13.1 TEVA Company Information
11.13.2 TEVA Cisplatin Product Offered
11.13.3 TEVA Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TEVA Main Business Overview
11.13.5 TEVA Latest Developments
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Information
11.14.2 Mylan Pharmaceuticals Cisplatin Product Offered
11.14.3 Mylan Pharmaceuticals Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Mylan Pharmaceuticals Main Business Overview
11.14.5 Mylan Pharmaceuticals Latest Developments
11.15 Yunnan Plant Pharmaceutical
11.15.1 Yunnan Plant Pharmaceutical Company Information
11.15.2 Yunnan Plant Pharmaceutical Cisplatin Product Offered
11.15.3 Yunnan Plant Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Yunnan Plant Pharmaceutical Main Business Overview
11.15.5 Yunnan Plant Pharmaceutical Latest Developments
11.16 Yunnan Biological Valley Pharmaceutical
11.16.1 Yunnan Biological Valley Pharmaceutical Company Information
11.16.2 Yunnan Biological Valley Pharmaceutical Cisplatin Product Offered
11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Yunnan Biological Valley Pharmaceutical Main Business Overview
11.16.5 Yunnan Biological Valley Pharmaceutical Latest Developments
11.17 Dezhou de Pharmaceutical
11.17.1 Dezhou de Pharmaceutical Company Information
11.17.2 Dezhou de Pharmaceutical Cisplatin Product Offered
11.17.3 Dezhou de Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Dezhou de Pharmaceutical Main Business Overview
11.17.5 Dezhou de Pharmaceutical Latest Developments
11.18 Jiangsu Haosen Pharmaceutical Group
11.18.1 Jiangsu Haosen Pharmaceutical Group Company Information
11.18.2 Jiangsu Haosen Pharmaceutical Group Cisplatin Product Offered
11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
11.18.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Company Information
11.19.2 Qilu Pharmaceutical Cisplatin Product Offered
11.19.3 Qilu Pharmaceutical Cisplatin Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Qilu Pharmaceutical Main Business Overview
11.19.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cisplatin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cisplatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Injection
Table 5. Cisplatin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cisplatin Market Size Market Share by Type (2020-2025)
Table 8. Cisplatin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cisplatin Market Size Market Share by Application (2020-2025)
Table 11. Global Cisplatin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cisplatin Revenue Market Share by Player (2020-2025)
Table 13. Cisplatin Key Players Head office and Products Offered
Table 14. Cisplatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cisplatin Market Size Market Share by Region (2020-2025)
Table 19. Global Cisplatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cisplatin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cisplatin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cisplatin Market Size Market Share by Country (2020-2025)
Table 23. Americas Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cisplatin Market Size Market Share by Type (2020-2025)
Table 25. Americas Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cisplatin Market Size Market Share by Application (2020-2025)
Table 27. APAC Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cisplatin Market Size Market Share by Region (2020-2025)
Table 29. APAC Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cisplatin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cisplatin Market Size Market Share by Country (2020-2025)
Table 33. Europe Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cisplatin
Table 39. Key Market Challenges & Risks of Cisplatin
Table 40. Key Industry Trends of Cisplatin
Table 41. Global Cisplatin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cisplatin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cisplatin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cisplatin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Eli Lilly and Company Details, Company Type, Cisplatin Area Served and Its Competitors
Table 46. Eli Lilly and Company Cisplatin Product Offered
Table 47. Eli Lilly and Company Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eli Lilly and Company Main Business
Table 49. Eli Lilly and Company Latest Developments
Table 50. Hospira Details, Company Type, Cisplatin Area Served and Its Competitors
Table 51. Hospira Cisplatin Product Offered
Table 52. Hospira Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Hospira Main Business
Table 54. Hospira Latest Developments
Table 55. Pfizer Details, Company Type, Cisplatin Area Served and Its Competitors
Table 56. Pfizer Cisplatin Product Offered
Table 57. Pfizer Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Bedford Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 61. Bedford Pharmaceuticals Cisplatin Product Offered
Table 62. Bedford Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bedford Pharmaceuticals Main Business
Table 64. Bedford Pharmaceuticals Latest Developments
Table 65. Alvogen Details, Company Type, Cisplatin Area Served and Its Competitors
Table 66. Alvogen Cisplatin Product Offered
Table 67. Alvogen Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Alvogen Main Business
Table 69. Alvogen Latest Developments
Table 70. Athenex Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 71. Athenex Pharmaceutical Cisplatin Product Offered
Table 72. Athenex Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Athenex Pharmaceutical Main Business
Table 74. Athenex Pharmaceutical Latest Developments
Table 75. Gland Pharma (Fosun Pharma) Details, Company Type, Cisplatin Area Served and Its Competitors
Table 76. Gland Pharma (Fosun Pharma) Cisplatin Product Offered
Table 77. Gland Pharma (Fosun Pharma) Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gland Pharma (Fosun Pharma) Main Business
Table 79. Gland Pharma (Fosun Pharma) Latest Developments
Table 80. West-Ward Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 81. West-Ward Pharmaceuticals Cisplatin Product Offered
Table 82. West-Ward Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. West-Ward Pharmaceuticals Main Business
Table 84. West-Ward Pharmaceuticals Latest Developments
Table 85. WG Critical Care Details, Company Type, Cisplatin Area Served and Its Competitors
Table 86. WG Critical Care Cisplatin Product Offered
Table 87. WG Critical Care Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. WG Critical Care Main Business
Table 89. WG Critical Care Latest Developments
Table 90. David Bull Laboratories Details, Company Type, Cisplatin Area Served and Its Competitors
Table 91. David Bull Laboratories Cisplatin Product Offered
Table 92. David Bull Laboratories Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. David Bull Laboratories Main Business
Table 94. David Bull Laboratories Latest Developments
Table 95. Omega Laboratories Details, Company Type, Cisplatin Area Served and Its Competitors
Table 96. Omega Laboratories Cisplatin Product Offered
Table 97. Omega Laboratories Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Omega Laboratories Main Business
Table 99. Omega Laboratories Latest Developments
Table 100. Fresenius Kabi Details, Company Type, Cisplatin Area Served and Its Competitors
Table 101. Fresenius Kabi Cisplatin Product Offered
Table 102. Fresenius Kabi Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Fresenius Kabi Main Business
Table 104. Fresenius Kabi Latest Developments
Table 105. TEVA Details, Company Type, Cisplatin Area Served and Its Competitors
Table 106. TEVA Cisplatin Product Offered
Table 107. TEVA Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. TEVA Main Business
Table 109. TEVA Latest Developments
Table 110. Mylan Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 111. Mylan Pharmaceuticals Cisplatin Product Offered
Table 112. Mylan Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Mylan Pharmaceuticals Main Business
Table 114. Mylan Pharmaceuticals Latest Developments
Table 115. Yunnan Plant Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 116. Yunnan Plant Pharmaceutical Cisplatin Product Offered
Table 117. Yunnan Plant Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Yunnan Plant Pharmaceutical Main Business
Table 119. Yunnan Plant Pharmaceutical Latest Developments
Table 120. Yunnan Biological Valley Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 121. Yunnan Biological Valley Pharmaceutical Cisplatin Product Offered
Table 122. Yunnan Biological Valley Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Yunnan Biological Valley Pharmaceutical Main Business
Table 124. Yunnan Biological Valley Pharmaceutical Latest Developments
Table 125. Dezhou de Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 126. Dezhou de Pharmaceutical Cisplatin Product Offered
Table 127. Dezhou de Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Dezhou de Pharmaceutical Main Business
Table 129. Dezhou de Pharmaceutical Latest Developments
Table 130. Jiangsu Haosen Pharmaceutical Group Details, Company Type, Cisplatin Area Served and Its Competitors
Table 131. Jiangsu Haosen Pharmaceutical Group Cisplatin Product Offered
Table 132. Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Jiangsu Haosen Pharmaceutical Group Main Business
Table 134. Jiangsu Haosen Pharmaceutical Group Latest Developments
Table 135. Qilu Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 136. Qilu Pharmaceutical Cisplatin Product Offered
Table 137. Qilu Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Qilu Pharmaceutical Main Business
Table 139. Qilu Pharmaceutical Latest Developments
Table 1. Cisplatin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cisplatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Injection
Table 5. Cisplatin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cisplatin Market Size Market Share by Type (2020-2025)
Table 8. Cisplatin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cisplatin Market Size Market Share by Application (2020-2025)
Table 11. Global Cisplatin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cisplatin Revenue Market Share by Player (2020-2025)
Table 13. Cisplatin Key Players Head office and Products Offered
Table 14. Cisplatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cisplatin Market Size Market Share by Region (2020-2025)
Table 19. Global Cisplatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cisplatin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cisplatin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cisplatin Market Size Market Share by Country (2020-2025)
Table 23. Americas Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cisplatin Market Size Market Share by Type (2020-2025)
Table 25. Americas Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cisplatin Market Size Market Share by Application (2020-2025)
Table 27. APAC Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cisplatin Market Size Market Share by Region (2020-2025)
Table 29. APAC Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cisplatin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cisplatin Market Size Market Share by Country (2020-2025)
Table 33. Europe Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cisplatin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cisplatin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cisplatin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cisplatin
Table 39. Key Market Challenges & Risks of Cisplatin
Table 40. Key Industry Trends of Cisplatin
Table 41. Global Cisplatin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cisplatin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cisplatin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cisplatin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Eli Lilly and Company Details, Company Type, Cisplatin Area Served and Its Competitors
Table 46. Eli Lilly and Company Cisplatin Product Offered
Table 47. Eli Lilly and Company Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eli Lilly and Company Main Business
Table 49. Eli Lilly and Company Latest Developments
Table 50. Hospira Details, Company Type, Cisplatin Area Served and Its Competitors
Table 51. Hospira Cisplatin Product Offered
Table 52. Hospira Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Hospira Main Business
Table 54. Hospira Latest Developments
Table 55. Pfizer Details, Company Type, Cisplatin Area Served and Its Competitors
Table 56. Pfizer Cisplatin Product Offered
Table 57. Pfizer Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Bedford Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 61. Bedford Pharmaceuticals Cisplatin Product Offered
Table 62. Bedford Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bedford Pharmaceuticals Main Business
Table 64. Bedford Pharmaceuticals Latest Developments
Table 65. Alvogen Details, Company Type, Cisplatin Area Served and Its Competitors
Table 66. Alvogen Cisplatin Product Offered
Table 67. Alvogen Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Alvogen Main Business
Table 69. Alvogen Latest Developments
Table 70. Athenex Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 71. Athenex Pharmaceutical Cisplatin Product Offered
Table 72. Athenex Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Athenex Pharmaceutical Main Business
Table 74. Athenex Pharmaceutical Latest Developments
Table 75. Gland Pharma (Fosun Pharma) Details, Company Type, Cisplatin Area Served and Its Competitors
Table 76. Gland Pharma (Fosun Pharma) Cisplatin Product Offered
Table 77. Gland Pharma (Fosun Pharma) Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gland Pharma (Fosun Pharma) Main Business
Table 79. Gland Pharma (Fosun Pharma) Latest Developments
Table 80. West-Ward Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 81. West-Ward Pharmaceuticals Cisplatin Product Offered
Table 82. West-Ward Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. West-Ward Pharmaceuticals Main Business
Table 84. West-Ward Pharmaceuticals Latest Developments
Table 85. WG Critical Care Details, Company Type, Cisplatin Area Served and Its Competitors
Table 86. WG Critical Care Cisplatin Product Offered
Table 87. WG Critical Care Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. WG Critical Care Main Business
Table 89. WG Critical Care Latest Developments
Table 90. David Bull Laboratories Details, Company Type, Cisplatin Area Served and Its Competitors
Table 91. David Bull Laboratories Cisplatin Product Offered
Table 92. David Bull Laboratories Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. David Bull Laboratories Main Business
Table 94. David Bull Laboratories Latest Developments
Table 95. Omega Laboratories Details, Company Type, Cisplatin Area Served and Its Competitors
Table 96. Omega Laboratories Cisplatin Product Offered
Table 97. Omega Laboratories Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Omega Laboratories Main Business
Table 99. Omega Laboratories Latest Developments
Table 100. Fresenius Kabi Details, Company Type, Cisplatin Area Served and Its Competitors
Table 101. Fresenius Kabi Cisplatin Product Offered
Table 102. Fresenius Kabi Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Fresenius Kabi Main Business
Table 104. Fresenius Kabi Latest Developments
Table 105. TEVA Details, Company Type, Cisplatin Area Served and Its Competitors
Table 106. TEVA Cisplatin Product Offered
Table 107. TEVA Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. TEVA Main Business
Table 109. TEVA Latest Developments
Table 110. Mylan Pharmaceuticals Details, Company Type, Cisplatin Area Served and Its Competitors
Table 111. Mylan Pharmaceuticals Cisplatin Product Offered
Table 112. Mylan Pharmaceuticals Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Mylan Pharmaceuticals Main Business
Table 114. Mylan Pharmaceuticals Latest Developments
Table 115. Yunnan Plant Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 116. Yunnan Plant Pharmaceutical Cisplatin Product Offered
Table 117. Yunnan Plant Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Yunnan Plant Pharmaceutical Main Business
Table 119. Yunnan Plant Pharmaceutical Latest Developments
Table 120. Yunnan Biological Valley Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 121. Yunnan Biological Valley Pharmaceutical Cisplatin Product Offered
Table 122. Yunnan Biological Valley Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Yunnan Biological Valley Pharmaceutical Main Business
Table 124. Yunnan Biological Valley Pharmaceutical Latest Developments
Table 125. Dezhou de Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 126. Dezhou de Pharmaceutical Cisplatin Product Offered
Table 127. Dezhou de Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Dezhou de Pharmaceutical Main Business
Table 129. Dezhou de Pharmaceutical Latest Developments
Table 130. Jiangsu Haosen Pharmaceutical Group Details, Company Type, Cisplatin Area Served and Its Competitors
Table 131. Jiangsu Haosen Pharmaceutical Group Cisplatin Product Offered
Table 132. Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Jiangsu Haosen Pharmaceutical Group Main Business
Table 134. Jiangsu Haosen Pharmaceutical Group Latest Developments
Table 135. Qilu Pharmaceutical Details, Company Type, Cisplatin Area Served and Its Competitors
Table 136. Qilu Pharmaceutical Cisplatin Product Offered
Table 137. Qilu Pharmaceutical Cisplatin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Qilu Pharmaceutical Main Business
Table 139. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Cisplatin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cisplatin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cisplatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cisplatin Sales Market Share by Country/Region (2024)
Figure 8. Cisplatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cisplatin Market Size Market Share by Type in 2024
Figure 10. Cisplatin in Testicular Cancer
Figure 11. Global Cisplatin Market: Testicular Cancer (2020-2025) & ($ millions)
Figure 12. Cisplatin in Osteosarcoma
Figure 13. Global Cisplatin Market: Osteosarcoma (2020-2025) & ($ millions)
Figure 14. Cisplatin in Breast Cancer
Figure 15. Global Cisplatin Market: Breast Cancer (2020-2025) & ($ millions)
Figure 16. Global Cisplatin Market Size Market Share by Application in 2024
Figure 17. Global Cisplatin Revenue Market Share by Player in 2024
Figure 18. Global Cisplatin Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cisplatin Market Size 2020-2025 ($ millions)
Figure 20. APAC Cisplatin Market Size 2020-2025 ($ millions)
Figure 21. Europe Cisplatin Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cisplatin Market Size 2020-2025 ($ millions)
Figure 23. Americas Cisplatin Value Market Share by Country in 2024
Figure 24. United States Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cisplatin Market Size Market Share by Region in 2024
Figure 29. APAC Cisplatin Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cisplatin Market Size Market Share by Application (2020-2025)
Figure 31. China Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cisplatin Market Size Market Share by Country in 2024
Figure 38. Europe Cisplatin Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cisplatin Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cisplatin Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cisplatin Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cisplatin Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cisplatin Market Size 2026-2031 ($ millions)
Figure 54. APAC Cisplatin Market Size 2026-2031 ($ millions)
Figure 55. Europe Cisplatin Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cisplatin Market Size 2026-2031 ($ millions)
Figure 57. United States Cisplatin Market Size 2026-2031 ($ millions)
Figure 58. Canada Cisplatin Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cisplatin Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cisplatin Market Size 2026-2031 ($ millions)
Figure 61. China Cisplatin Market Size 2026-2031 ($ millions)
Figure 62. Japan Cisplatin Market Size 2026-2031 ($ millions)
Figure 63. Korea Cisplatin Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cisplatin Market Size 2026-2031 ($ millions)
Figure 65. India Cisplatin Market Size 2026-2031 ($ millions)
Figure 66. Australia Cisplatin Market Size 2026-2031 ($ millions)
Figure 67. Germany Cisplatin Market Size 2026-2031 ($ millions)
Figure 68. France Cisplatin Market Size 2026-2031 ($ millions)
Figure 69. UK Cisplatin Market Size 2026-2031 ($ millions)
Figure 70. Italy Cisplatin Market Size 2026-2031 ($ millions)
Figure 71. Russia Cisplatin Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cisplatin Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cisplatin Market Size 2026-2031 ($ millions)
Figure 74. Israel Cisplatin Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cisplatin Market Size 2026-2031 ($ millions)
Figure 76. Global Cisplatin Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cisplatin Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cisplatin Market Size 2026-2031 ($ millions)
Figure 1. Cisplatin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cisplatin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cisplatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cisplatin Sales Market Share by Country/Region (2024)
Figure 8. Cisplatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cisplatin Market Size Market Share by Type in 2024
Figure 10. Cisplatin in Testicular Cancer
Figure 11. Global Cisplatin Market: Testicular Cancer (2020-2025) & ($ millions)
Figure 12. Cisplatin in Osteosarcoma
Figure 13. Global Cisplatin Market: Osteosarcoma (2020-2025) & ($ millions)
Figure 14. Cisplatin in Breast Cancer
Figure 15. Global Cisplatin Market: Breast Cancer (2020-2025) & ($ millions)
Figure 16. Global Cisplatin Market Size Market Share by Application in 2024
Figure 17. Global Cisplatin Revenue Market Share by Player in 2024
Figure 18. Global Cisplatin Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cisplatin Market Size 2020-2025 ($ millions)
Figure 20. APAC Cisplatin Market Size 2020-2025 ($ millions)
Figure 21. Europe Cisplatin Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cisplatin Market Size 2020-2025 ($ millions)
Figure 23. Americas Cisplatin Value Market Share by Country in 2024
Figure 24. United States Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cisplatin Market Size Market Share by Region in 2024
Figure 29. APAC Cisplatin Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cisplatin Market Size Market Share by Application (2020-2025)
Figure 31. China Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cisplatin Market Size Market Share by Country in 2024
Figure 38. Europe Cisplatin Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cisplatin Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cisplatin Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cisplatin Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cisplatin Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cisplatin Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cisplatin Market Size 2026-2031 ($ millions)
Figure 54. APAC Cisplatin Market Size 2026-2031 ($ millions)
Figure 55. Europe Cisplatin Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cisplatin Market Size 2026-2031 ($ millions)
Figure 57. United States Cisplatin Market Size 2026-2031 ($ millions)
Figure 58. Canada Cisplatin Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cisplatin Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cisplatin Market Size 2026-2031 ($ millions)
Figure 61. China Cisplatin Market Size 2026-2031 ($ millions)
Figure 62. Japan Cisplatin Market Size 2026-2031 ($ millions)
Figure 63. Korea Cisplatin Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cisplatin Market Size 2026-2031 ($ millions)
Figure 65. India Cisplatin Market Size 2026-2031 ($ millions)
Figure 66. Australia Cisplatin Market Size 2026-2031 ($ millions)
Figure 67. Germany Cisplatin Market Size 2026-2031 ($ millions)
Figure 68. France Cisplatin Market Size 2026-2031 ($ millions)
Figure 69. UK Cisplatin Market Size 2026-2031 ($ millions)
Figure 70. Italy Cisplatin Market Size 2026-2031 ($ millions)
Figure 71. Russia Cisplatin Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cisplatin Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cisplatin Market Size 2026-2031 ($ millions)
Figure 74. Israel Cisplatin Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cisplatin Market Size 2026-2031 ($ millions)
Figure 76. Global Cisplatin Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cisplatin Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cisplatin Market Size 2026-2031 ($ millions)
More Publications
Global Dental Zirconia Block Market Growth 2025-2031
US$ 3,660.00
December 2024
125 pages
Global Medical Linear Accelerator Market Growth 2025-2031
US$ 3,660.00
December 2024
80 pages
Global Body Temperature Monitoring Devices Market Growth 2025-2031
US$ 3,660.00
March 2025
147 pages
Global ENT Chairs Market Growth 2025-2031
US$ 3,660.00
December 2024
119 pages
Global Pharmaceutical Grade Sodium Chloride Market Growth 2025-2031
US$ 3,660.00
December 2024
119 pages
